Fwd: Alert to U.S. Clinicians: Global emergence of invasive infections caused by the multidrug-resistant yeast, Candida auris

USRS. Grs

4 cover

Health, infectious disease

Dr. Michael D. McDonald

Coordinator
Global Health Response and Resilience Alliance

Chairman
Global Resilience Systems, Inc.

President
Health Initiatives Foundation, Inc.

Michael.D.McDonald@mac.com
202-468-7899

Begin forwarded message:

> From: Kathy Gilbeaux <gilbojer@aol.com>
> Date: June 27, 2016 at 10:07:03 PM EDT
> To: lajeuneconsulting@gmail.com
> Cc: michael.d.mcdonald@mac.com
> Subject: Re: Alert to U.S. Clinicians: Global emergence of invasive infections caused by the multidrug-resistant yeast, Candida auris
>
> Carrie,
>
> Thank you. These drug-resistant bugs are very scary. It is always interesting to learn how they got started. Here is the scoop on this bug . . .
>
> In 2009, yeast isolates from the external ear canal of a Japanese patient were identified as a new species, Can- dida auris, on the basis of sequence analysis of the nuclear rRNA gene . . .
>
> . . . most (83%) of the patients in our study had an indwelling urinary catheter, the source of fungemia could be urogenital colonization. However, no urine samples were cultured.
>
> https://wwwnc.cdc.gov/eid/article/19/10/pdfs/13-0393.pdf
>
> Kathy
>
>
> -----Original Message-----
> From: Carrie La Jeunesse <lajeuneconsulting@gmail.com>
> To: Kathy Gilbeaux <gilbojer@aol.com>
> Sent: Mon, Jun 27, 2016 4:16 pm
> Subject: Fwd: Alert to U.S. Clinicians: Global emergence of invasive infections caused by the multidrug-resistant yeast, Candida auris
>
> Kathy,
> FYI
>
> http://www.cdc.gov/fungal/diseases/candidiasis/candida-auris-alert.html
>
> Carrie
>
>
> Dr. Carolyn La Jeunesse DVM, CT, CFE
> LaJeune Consulting
> www.lajeuneconsulting.com
> +1 360 731 0493
> twitter: carrielaj6
>
> ---------- Forwarded message ----------
> From: Centers for Disease Control & Prevention <cdc@service.govdelivery.com>
> Date: Mon, Jun 27, 2016 at 3:33 PM
> Subject: Alert to U.S. Clinicians: Global emergence of invasive infections caused by the multidrug-resistant yeast, Candida auris
> To: Lajeuneconsulting@gmail.com
>
>
> Alert to U.S. Clinicians: Global emergence of invasive infections caused by the multidrug-resistant yeast, Candida auris
>
> Clinical Alert: Global Emergence of Invasive Infections Caused by the Multidrug-resistant Yeast Candida auris
> The Centers for Disease Control and Prevention (CDC) has received reports from international healthcare facilities that Candida auris, an emerging multidrug-resistant yeast, is causing invasive healthcare-associated infections with high mortality. Some strains of C. auris have elevated minimum inhibitory concentrations (MICs) to the three major classes of antifungals, severely limiting treatment options. C. auris requires specialized methods for identification and could be misidentified as another yeast when relying on traditional biochemical methods. CDC is aware of one isolate of C. auris that was detected in the United States in 2013 as part of ongoing surveillance. Experience outside the United States suggests that C. auris has high potential to cause outbreaks in healthcare facilities. Given the occurrence of C. auris in nine countries on four continents since 2009, CDC is alerting U.S. healthcare facilities to be on the lookout for C. auris in patients.
> Please read CDC’s recommendations for identifying and managing patients with C. auris: http://www.cdc.gov/fungal/diseases/candidiasis/candida-auris-alert.html
> In case you missed CDC's recent clinical alerts:
> B. cepacia ALERT - CDC Recommends Clinicians Immediately Stop Using Liquid Docusate for Certain Patients: http://www.cdc.gov/hai/outbreaks/b-cepacia/index.html
> mcr-1 ALERT - First mcr-1 Gene in E. coli Bacteria found in a Human in the United States: http://emergency.cdc.gov/han/han00390.asp
> The CDC has reached over 1 million email subscribers. Thank you for your support.
> Modify/Update Subscriber Preferences or Unsubscribe | Learn about CDC Updates
> Questions or problems? Please contact support@govdelivery.com.
>
>
>
> This email was sent to Lajeuneconsulting@gmail.com using GovDelivery,on behalf of: Centers for Disease Control and Prevention • 1600 Clifton Rd • Atlanta, GA 30333 • 1-800-CDC-INFO (800-232-4636)
>
>